beginning at 18 weeks of age. LacZ staining showed
that the doxycycline regimen abolished expression of expanded polyglutamine tract could make the protein resistant to degradation by altering its native structure; the transgene. After 16 weeks of treatment the polyglutamine aggregates disappeared in the "gene-off" mice, in vitro studies show that ataxin-1 with an expanded polyglutamine tract is less efficiently degraded than its and all the progressive striatal changes (decrease in size, gliosis, and loss of D1 receptors) were arrested. (Saigoh et al., 1999) . Uchl1 hydrospecific recognition, one is again faced with the need lyzes bonds between degraded end products and ubito have a specific therapeutic approach for each of these quitin to generate free monomeric ubiquitin; the deletion diseases. Should future research identify a unique strucremoves 42 amino acids that contain a catalytic residue, tural property of proteins that undergo oligomerization thus compromising the free ubiquitin pool necessary for and accumulation in these diseases, then perhaps a an intact UPP. The SCA1 phenotype was recently found strategy that enhances the activity of a protease that to be accelerated by loss of function of an E3 ligase selectively degrades such proteins would become an (Ube3a) (Cummings et al., 1999) 
